Where next for China’s Belt and Road?

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  Show more

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — ar ...  Show more

This month China’s President Xi Jinping is expected to secure a further five years as the country’s leader after the Communist Party abolished two-term limits. It opens the door to Xi continuing to rule for the rest of his life. His time in power has seen the country take a more ...  Show more

En Chine, l’activité industrielle est repartie sur les chapeaux de roue en février. L'économie chinoise semble se relever plus rapidement que prévu. Elle sort de trois ans d’isolement imposé au nom de la politique « zéro covid ». Ces bons chiffres de l'industrie sont bienvenus à ...  Show more

China is not happy that some countries are placing restrictions on some travellers because of the sharp increase of Covid cases in the country. China's foreign ministry said the country is firmly opposed to "attempts to manipulate the epidemic prevention and control measures for ...  Show more

Correction: We re-uploaded this episode to clarify the $1.5 trillion mentioned in the conversation was China's global loans, not just to Africa. At a recent summit attended by African officials, Chinese Foreign Minister Wang Yi announced that China would be forgiving 23 of its lo ...  Show more